accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001062993-26-004806 | 1997296 | Medicus Pharma Ltd. | null | 2026-09-03 | 8-K | ind | false | exhibit10-1.htm | https://www.sec.gov/Archives/edgar/data/1997296/000106299326004806/exhibit10-1.htm |
0001104659-26-104929 | 1819576 | Liquidia Corp | LQDA | 2026-09-03 | 8-K | fast_track | false | tm2624724d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1819576/000110465926104929/tm2624724d1_ex99-1.htm |
0001193125-26-381912 | 2056611 | Latigo Biotherapeutics, Inc. | LTGO | 2026-09-03 | 8-K | topline | false | ltgo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2056611/000119312526381912/ltgo-ex99_1.htm |
0001193125-26-381912 | 2056611 | Latigo Biotherapeutics, Inc. | LTGO | 2026-09-03 | 8-K | endpoint_met | false | ltgo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2056611/000119312526381912/ltgo-ex99_1.htm |
0001193125-26-381060 | 1768446 | Climb Bio, Inc. | CLYM | 2026-09-03 | 8-K | topline | false | d97033dex991.htm | https://www.sec.gov/Archives/edgar/data/1768446/000119312526381060/d97033dex991.htm |
0001193125-26-381098 | 1671584 | Aptevo Therapeutics Inc. | APVO | 2026-09-03 | 8-K | orphan | false | apvo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1671584/000119312526381098/apvo-ex99_1.htm |
0001104659-26-104463 | 1590560 | uniQure N.V. | QURE | 2026-09-02 | 8-K | breakthrough | false | qure-20260902xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1590560/000110465926104463/qure-20260902xex99d1.htm |
0001104659-26-104463 | 1590560 | uniQure N.V. | QURE | 2026-09-02 | 8-K | fast_track | false | qure-20260902xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1590560/000110465926104463/qure-20260902xex99d1.htm |
0001193125-26-378838 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-09-02 | 8-K | ind | false | d113784dex11.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526378838/d113784dex11.htm |
0000886163-26-000048 | 886163 | LIGAND PHARMACEUTICALS INC | null | 2026-09-02 | 8-K | topline | false | exhibit992unauditedcondens.htm | https://www.sec.gov/Archives/edgar/data/886163/000088616326000048/exhibit992unauditedcondens.htm |
0001493152-26-041253 | 1725430 | INTELLIGENT BIO SOLUTIONS INC. | INBS | 2026-09-02 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1725430/000149315226041253/ex10-1.htm |
0001193125-26-380215 | 2058707 | Attovia Therapeutics, Inc. | ATTO | 2026-09-02 | 8-K | ind | false | atto-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2058707/000119312526380215/atto-ex99_1.htm |
0001493152-26-040930 | 1904286 | MIRA PHARMACEUTICALS, INC. | MIRA | 2026-09-01 | 8-K | ind | false | form8-k.htm | https://www.sec.gov/Archives/edgar/data/1904286/000149315226040930/form8-k.htm |
0001193125-26-377493 | 1832038 | Invivyd, Inc. | IVVD | 2026-09-01 | 8-K | topline | false | ivvd-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1832038/000119312526377493/ivvd-ex99_1.htm |
0001493152-26-040926 | 1857044 | Indaptus Therapeutics, Inc. | INDP | 2026-09-01 | 8-K | clinical_hold | true | ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/ex1-1.htm |
0001140361-26-035189 | 1124105 | GYRE THERAPEUTICS, INC. | GYRE | 2026-09-01 | 8-K | breakthrough | false | ef20081441_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1124105/000114036126035189/ef20081441_ex99-1.htm |
0001720580-26-000054 | 1720580 | Adicet Bio, Inc. | ACET | 2026-09-01 | 8-K | topline | false | acet-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1720580/000172058026000054/acet-ex99_1.htm |
0001720580-26-000054 | 1720580 | Adicet Bio, Inc. | ACET | 2026-09-01 | 8-K | ind | false | acet-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1720580/000172058026000054/acet-ex99_1.htm |
0001104659-26-104145 | 1847367 | ALUMIS INC. | ALMS | 2026-09-01 | 8-K | topline | false | tm2624540d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1847367/000110465926104145/tm2624540d1_ex99-2.htm |
0001213900-26-095686 | 1560293 | Tenon Medical, Inc. | null | 2026-08-31 | 8-K | clinical_hold | true | ea030388301ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1560293/000121390026095686/ea030388301ex10-1.htm |
0001193125-26-376723 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-08-31 | 8-K | fast_track | false | d441751dex991.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526376723/d441751dex991.htm |
0001193125-26-376723 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-08-31 | 8-K | orphan | false | d441751dex991.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526376723/d441751dex991.htm |
0001193125-26-375495 | 1503802 | Karyopharm Therapeutics Inc. | KPTI | 2026-08-31 | 8-K | topline | false | d423030d8k.htm | https://www.sec.gov/Archives/edgar/data/1503802/000119312526375495/d423030d8k.htm |
0001213900-26-095394 | 1937993 | Cadrenal Therapeutics, Inc. | CVKD | 2026-08-31 | 8-K | fast_track | false | ea030399701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1937993/000121390026095394/ea030399701ex99-1.htm |
0001213900-26-095394 | 1937993 | Cadrenal Therapeutics, Inc. | CVKD | 2026-08-31 | 8-K | orphan | false | ea030399701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1937993/000121390026095394/ea030399701ex99-1.htm |
0001140361-26-035055 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-08-31 | 8-K | pdufa | false | ef20081330_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/ef20081330_ex99-1.htm |
0001193125-26-374328 | 1001233 | SANGAMO THERAPEUTICS, INC | SGMOQ | 2026-08-28 | 8-K | ind | false | d116527dex21.htm | https://www.sec.gov/Archives/edgar/data/1001233/000119312526374328/d116527dex21.htm |
0001140361-26-034854 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-08-28 | 8-K | topline | false | ef20081283_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1635088/000114036126034854/ef20081283_ex99-1.htm |
0001104659-26-102917 | 1671502 | Quoin Pharmaceuticals, Ltd. | QNRX | 2026-08-28 | 8-K | topline | false | tm2624258d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/tm2624258d1_ex99-2.htm |
0001104659-26-102917 | 1671502 | Quoin Pharmaceuticals, Ltd. | QNRX | 2026-08-28 | 8-K | endpoint_met | false | tm2624258d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/tm2624258d1_ex99-2.htm |
0001104659-26-102917 | 1671502 | Quoin Pharmaceuticals, Ltd. | QNRX | 2026-08-28 | 8-K | interim | false | tm2624258d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/tm2624258d1_ex99-2.htm |
0001104659-26-102917 | 1671502 | Quoin Pharmaceuticals, Ltd. | QNRX | 2026-08-28 | 8-K | clinical_hold | true | tm2624258d1_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/tm2624258d1_ex10-1.htm |
0001104659-26-102917 | 1671502 | Quoin Pharmaceuticals, Ltd. | QNRX | 2026-08-28 | 8-K | orphan | false | tm2624258d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926102917/tm2624258d1_ex99-2.htm |
0001213900-26-094638 | 1158780 | Pluri Inc. | PLUR | 2026-08-28 | 8-K | clinical_hold | true | ea030358201ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1158780/000121390026094638/ea030358201ex10-1.htm |
0001213900-26-094638 | 1158780 | Pluri Inc. | PLUR | 2026-08-28 | 8-K | ind | false | ea030358201ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1158780/000121390026094638/ea030358201ex10-1.htm |
0001140361-26-034735 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-08-27 | 8-K | topline | false | ef20081229_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1635088/000114036126034735/ef20081229_ex99-1.htm |
0001140361-26-034735 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-08-27 | 8-K | orphan | false | ef20081229_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1635088/000114036126034735/ef20081229_ex99-1.htm |
0001193125-26-369674 | 1776111 | MBX Biosciences, Inc. | MBX | 2026-08-27 | 8-K | orphan | false | mbx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1776111/000119312526369674/mbx-ex99_1.htm |
0001213900-26-094429 | 1907223 | Greenland Mines Ltd | null | 2026-08-27 | 8-K | clinical_hold | true | ea030353701ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1907223/000121390026094429/ea030353701ex10-1.htm |
0001628280-26-059262 | 39911 | GAP INC | GAP | 2026-08-27 | 8-K | topline | false | q22026eprexhibit991.htm | https://www.sec.gov/Archives/edgar/data/39911/000162828026059262/q22026eprexhibit991.htm |
0001213900-26-094422 | 2108359 | BioKey (Cayman), Inc. | null | 2026-08-27 | 8-K | clinical_hold | true | ea030361701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/2108359/000121390026094422/ea030361701ex99-1.htm |
0001213900-26-094153 | 2108359 | BioKey (Cayman), Inc. | null | 2026-08-27 | 8-K | clinical_hold | true | ea030290601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/2108359/000121390026094153/ea030290601ex99-1.htm |
0001599298-26-000074 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-08-26 | 8-K | topline | false | smmt-20260825.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000074/smmt-20260825.htm |
0001599298-26-000074 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-08-26 | 8-K | interim | false | smmt-20260825.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000074/smmt-20260825.htm |
0001599298-26-000074 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-08-26 | 8-K | pdufa | false | a2026_prx0825xharmoni-gi.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000074/a2026_prx0825xharmoni-gi.htm |
0001193125-26-368288 | 1620463 | LeonaBio, Inc. | LONA | 2026-08-26 | 8-K | crl | true | lona-20260826.htm | https://www.sec.gov/Archives/edgar/data/1620463/000119312526368288/lona-20260826.htm |
0001140361-26-034401 | 1124105 | GYRE THERAPEUTICS, INC. | GYRE | 2026-08-26 | 8-K | endpoint_met | false | ef20081104_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/ef20081104_ex99-1.htm |
0001140361-26-034401 | 1124105 | GYRE THERAPEUTICS, INC. | GYRE | 2026-08-26 | 8-K | breakthrough | false | ef20081104_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/ef20081104_ex99-1.htm |
0001935979-26-000072 | 1935979 | Biohaven Ltd. | BHVN | 2026-08-26 | 8-K | topline | false | exhibit991-biohavenandskbi.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000072/exhibit991-biohavenandskbi.htm |
0001935979-26-000072 | 1935979 | Biohaven Ltd. | BHVN | 2026-08-26 | 8-K | clinical_hold | true | exhibit101-licenseagreemen.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000072/exhibit101-licenseagreemen.htm |
0001935979-26-000072 | 1935979 | Biohaven Ltd. | BHVN | 2026-08-26 | 8-K | ind | false | exhibit101-licenseagreemen.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000072/exhibit101-licenseagreemen.htm |
0001493152-26-040251 | 73290 | BIOMERICA INC | BMRA | 2026-08-26 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/73290/000149315226040251/ex10-1.htm |
0001937653-26-000051 | 1937653 | Zymeworks Inc. | ZYME | 2026-08-25 | 8-K | ind | false | finalgeapr.htm | https://www.sec.gov/Archives/edgar/data/1937653/000193765326000051/finalgeapr.htm |
0001636282-26-000105 | 1636282 | Spyre Therapeutics, Inc. | SYRE | 2026-08-25 | 8-K | topline | false | spyre-20260825xexx991.htm | https://www.sec.gov/Archives/edgar/data/1636282/000163628226000105/spyre-20260825xexx991.htm |
0001213900-26-093244 | 1873875 | Incannex Healthcare Inc. | IXHL | 2026-08-25 | 8-K | fast_track | false | ea030314001ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873875/000121390026093244/ea030314001ex99-1.htm |
0001104659-26-100532 | 1720893 | BioXcel Therapeutics, Inc. | BTAI | 2026-08-25 | 8-K | ind | false | tm2623945d1_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1720893/000110465926100532/tm2623945d1_ex10-1.htm |
0001104659-26-100470 | 1828185 | Barinthus Biotherapeutics plc. | BRNS | 2026-08-25 | 8-K | topline | false | tm2623930d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1828185/000110465926100470/tm2623930d1_ex99-1.htm |
0001731122-26-001143 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-08-25 | 8-K | breakthrough | false | e7897_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001143/e7897_ex99-1.htm |
0001731122-26-001143 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-08-25 | 8-K | fast_track | false | e7897_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001143/e7897_ex99-1.htm |
0001731122-26-001143 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-08-25 | 8-K | orphan | false | e7897_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001143/e7897_ex99-1.htm |
0001193125-26-363786 | 1590877 | REGENXBIO Inc. | RGNX | 2026-08-24 | 8-K | clinical_hold | true | rgnx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1590877/000119312526363786/rgnx-ex99_1.htm |
0001193125-26-363786 | 1590877 | REGENXBIO Inc. | RGNX | 2026-08-24 | 8-K | ind | false | rgnx-20260824.htm | https://www.sec.gov/Archives/edgar/data/1590877/000119312526363786/rgnx-20260824.htm |
0001628280-26-058512 | 1357874 | PRECISION BIOSCIENCES INC | DTIL | 2026-08-24 | 8-K | fast_track | false | a08242026dmdfpdpressrelease.htm | https://www.sec.gov/Archives/edgar/data/1357874/000162828026058512/a08242026dmdfpdpressrelease.htm |
0001628280-26-058512 | 1357874 | PRECISION BIOSCIENCES INC | DTIL | 2026-08-24 | 8-K | orphan | false | a08242026dmdfpdpressrelease.htm | https://www.sec.gov/Archives/edgar/data/1357874/000162828026058512/a08242026dmdfpdpressrelease.htm |
0001213900-26-093028 | 1721484 | Longeveron Inc. | LGVN | 2026-08-24 | 8-K | topline | false | ea030309701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026093028/ea030309701ex99-1.htm |
0001213900-26-093028 | 1721484 | Longeveron Inc. | LGVN | 2026-08-24 | 8-K | fast_track | false | ea030309701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026093028/ea030309701ex99-1.htm |
0001213900-26-093028 | 1721484 | Longeveron Inc. | LGVN | 2026-08-24 | 8-K | orphan | false | ea030309701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026093028/ea030309701ex99-1.htm |
0001213900-26-093122 | 1907223 | Greenland Mines Ltd | null | 2026-08-24 | 8-K | clinical_hold | true | ea030316201ex1-01.htm | https://www.sec.gov/Archives/edgar/data/1907223/000121390026093122/ea030316201ex1-01.htm |
0001213900-26-093122 | 1907223 | Greenland Mines Ltd | null | 2026-08-24 | 8-K | ind | false | ea030316201ex1-01.htm | https://www.sec.gov/Archives/edgar/data/1907223/000121390026093122/ea030316201ex1-01.htm |
0001193125-26-361895 | 1761918 | Erasca, Inc. | ERAS | 2026-08-24 | 8-K | fast_track | false | eras-20260824.htm | https://www.sec.gov/Archives/edgar/data/1761918/000119312526361895/eras-20260824.htm |
0001104659-26-100071 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-08-24 | 8-K | endpoint_met | false | capr-20260824xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926100071/capr-20260824xex99d1.htm |
0001104659-26-100071 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-08-24 | 8-K | pdufa | false | capr-20260824xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926100071/capr-20260824xex99d1.htm |
0001437749-26-028778 | 925741 | BioCardia, Inc. | BCDA | 2026-08-24 | 8-K | topline | false | ex_1008188.htm | https://www.sec.gov/Archives/edgar/data/925741/000143774926028778/ex_1008188.htm |
0001193125-26-360059 | 1785530 | Werewolf Therapeutics, Inc. | HOWL | 2026-08-21 | 8-K | topline | false | d102535dex991.htm | https://www.sec.gov/Archives/edgar/data/1785530/000119312526360059/d102535dex991.htm |
0001193125-26-360059 | 1785530 | Werewolf Therapeutics, Inc. | HOWL | 2026-08-21 | 8-K | interim | false | d102535dex992.htm | https://www.sec.gov/Archives/edgar/data/1785530/000119312526360059/d102535dex992.htm |
0001193125-26-360059 | 1785530 | Werewolf Therapeutics, Inc. | HOWL | 2026-08-21 | 8-K | clinical_hold | true | d102535dex21.htm | https://www.sec.gov/Archives/edgar/data/1785530/000119312526360059/d102535dex21.htm |
0001213900-26-092661 | 1734005 | Niki BioSolutions, Inc. | NIKI | 2026-08-21 | 8-K | orphan | false | ea030254401ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1734005/000121390026092661/ea030254401ex99-2.htm |
0001728117-26-000077 | 1728117 | Gossamer Bio, Inc. | GOSS | 2026-08-21 | 8-K | crl | true | goss-20260820.htm | https://www.sec.gov/Archives/edgar/data/1728117/000172811726000077/goss-20260820.htm |
0001493152-26-039565 | 1701478 | Azitra, Inc. | AZTR | 2026-08-21 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226039565/ex99-1.htm |
0001493152-26-039565 | 1701478 | Azitra, Inc. | AZTR | 2026-08-21 | 8-K | fast_track | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226039565/ex99-1.htm |
0001493152-26-039410 | 1022899 | Protagenic Therapeutics, Inc.\new | PTIX | 2026-08-20 | 8-K | clinical_hold | true | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1022899/000149315226039410/ex99-1.htm |
0001829126-26-009173 | 1527352 | Nexalin Technology, Inc. | NXL | 2026-08-20 | 8-K | clinical_hold | true | nexalintec_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1527352/000182912626009173/nexalintec_ex10-1.htm |
0001171843-26-005686 | 1540159 | Edesa Biotech, Inc. | EDSA | 2026-08-20 | 8-K | topline | false | exh_992.htm | https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/exh_992.htm |
0001193125-26-359418 | 1658551 | Amylyx Pharmaceuticals, Inc. | AMLX | 2026-08-20 | 8-K | clinical_hold | true | d179247dex11.htm | https://www.sec.gov/Archives/edgar/data/1658551/000119312526359418/d179247dex11.htm |
0001213900-26-091677 | 1721484 | Longeveron Inc. | LGVN | 2026-08-19 | 8-K | topline | false | ea030272301ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026091677/ea030272301ex99-1.htm |
0001213900-26-091677 | 1721484 | Longeveron Inc. | LGVN | 2026-08-19 | 8-K | fast_track | false | ea030272301ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026091677/ea030272301ex99-1.htm |
0001213900-26-091677 | 1721484 | Longeveron Inc. | LGVN | 2026-08-19 | 8-K | orphan | false | ea030272301ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026091677/ea030272301ex99-1.htm |
0001372514-26-000077 | 1372514 | KIORA PHARMACEUTICALS INC | null | 2026-08-19 | 8-K | ind | false | ex101-exclusivelicenseagre.htm | https://www.sec.gov/Archives/edgar/data/1372514/000137251426000077/ex101-exclusivelicenseagre.htm |
0001213900-26-091749 | 1282980 | Dror Ortho-Design, Inc. | DROR | 2026-08-19 | 8-K | clinical_hold | true | ea030275201ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1282980/000121390026091749/ea030275201ex10-1.htm |
0001129928-26-000053 | 1129928 | ONCOLYTICS BIOTECH INC | ONCY | 2026-08-18 | 8-K | fast_track | false | oncolyticscrcfdafeedback.htm | https://www.sec.gov/Archives/edgar/data/1129928/000112992826000053/oncolyticscrcfdafeedback.htm |
0001193125-26-354780 | 1048477 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2026-08-18 | 8-K | clinical_hold | true | d172628dex21.htm | https://www.sec.gov/Archives/edgar/data/1048477/000119312526354780/d172628dex21.htm |
0001193125-26-354780 | 1048477 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2026-08-18 | 8-K | ind | false | d172628dex21.htm | https://www.sec.gov/Archives/edgar/data/1048477/000119312526354780/d172628dex21.htm |
0001193125-26-354793 | 1658551 | Amylyx Pharmaceuticals, Inc. | AMLX | 2026-08-18 | 8-K | topline | false | d184004dex991.htm | https://www.sec.gov/Archives/edgar/data/1658551/000119312526354793/d184004dex991.htm |
0001193125-26-354716 | 1658551 | Amylyx Pharmaceuticals, Inc. | AMLX | 2026-08-18 | 8-K | topline | false | d180533d8k.htm | https://www.sec.gov/Archives/edgar/data/1658551/000119312526354716/d180533d8k.htm |
0001193125-26-354716 | 1658551 | Amylyx Pharmaceuticals, Inc. | AMLX | 2026-08-18 | 8-K | endpoint_met | false | d180533d8k.htm | https://www.sec.gov/Archives/edgar/data/1658551/000119312526354716/d180533d8k.htm |
0001193125-26-354716 | 1658551 | Amylyx Pharmaceuticals, Inc. | AMLX | 2026-08-18 | 8-K | breakthrough | false | d180533dex991.htm | https://www.sec.gov/Archives/edgar/data/1658551/000119312526354716/d180533dex991.htm |
0001193125-26-354716 | 1658551 | Amylyx Pharmaceuticals, Inc. | AMLX | 2026-08-18 | 8-K | orphan | false | d180533dex991.htm | https://www.sec.gov/Archives/edgar/data/1658551/000119312526354716/d180533dex991.htm |
0001104659-26-097526 | 1855644 | Zura Bio Ltd | ZURA | 2026-08-17 | 8-K | topline | false | tm2623351d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1855644/000110465926097526/tm2623351d1_ex99-1.htm |
0001104659-26-097526 | 1855644 | Zura Bio Ltd | ZURA | 2026-08-17 | 8-K | endpoint_met | false | tm2623351d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1855644/000110465926097526/tm2623351d1_ex99-1.htm |
0001437749-26-028111 | 1719406 | NRX Pharmaceuticals, Inc. | NRXP | 2026-08-17 | 8-K | breakthrough | false | ex_1005774.htm | https://www.sec.gov/Archives/edgar/data/1719406/000143774926028111/ex_1005774.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.